Cargando…
Chemotherapeutic drugs stimulate the release and recycling of extracellular vesicles to assist cancer cells in developing an urgent chemoresistance
BACKGROUND: Chemotherapy is a widely used treatment for cancer. However, the development of acquired multidrug resistance (MDR) is a serious issue. Emerging evidence has shown that the extracellular vesicles (EVs) mediate MDR, but the underlying mechanism remains unclear, especially the effects of c...
Autores principales: | Wang, Xiaokun, Qiao, Dongjuan, Chen, Likun, Xu, Meng, Chen, Shupeng, Huang, Liyan, Wang, Fang, Chen, Zhen, Cai, Jiye, Fu, Liwu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907227/ https://www.ncbi.nlm.nih.gov/pubmed/31830995 http://dx.doi.org/10.1186/s12943-019-1114-z |
Ejemplares similares
-
Overcoming Chemoresistance via Extracellular Vesicle Inhibition
por: Hayatudin, Raeesah, et al.
Publicado: (2021) -
Cetuximab enhanced the efficacy of chemotherapeutic agent in ABCB1/P-glycoprotein-overexpressing cancer cells
por: Wang, Fang, et al.
Publicado: (2015) -
Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion
por: Tian, Wanjia, et al.
Publicado: (2022) -
Hydroxychloroquine Enhances Cytotoxic Properties of Extracellular Vesicles and Extracellular Vesicle–Mimetic Nanovesicles Loaded with Chemotherapeutics
por: Brezgin, Sergey, et al.
Publicado: (2023) -
Extracellular Vesicles and the Inflammasome: An Intricate Network Sustaining Chemoresistance
por: Mezzasoma, Letizia, et al.
Publicado: (2022)